Meng W, Meng S, Hampel R, Ventz M, Männchen E, Weber W, Streckenbach B
Abteilung für Endokrinologie und Stoffwechselkrankheiten Klinik für Innere Medizin Ernst-Moritz-Arndt-Universität Greifswald.
Dtsch Z Verdau Stoffwechselkr. 1987;47(6):337-40.
Up to now the results of drug treatment are unsatisfying. Treatment of more than 1-2 years did not decrease the occurrence of relapses. Thyroid suppression test and TRH test give the same indications concerning the outcome in cases with Graves' disease and disseminated autonomy (short-time prognosis). The relapse rate is distinctly higher in Graves' disease than in cases with disseminated autonomy (goitre class 3 excluded).